Latest Integration News

Brazilian Critical Minerals has achieved a significant milestone in its Ema project by successfully demonstrating magnesium sulphate migration and pH reduction in field trials, validating its in-situ recovery method for rare earth elements.

Viridis Mining and Minerals has been selected for a major Brazilian government funding package to accelerate its Colossus rare earth elements project, marking a pivotal step in diversifying global critical mineral supply chains.

Meteoric Resources has secured inclusion in Brazil’s major Strategic Minerals funding program, aiming to advance its Caldeira Rare Earths Project and downstream magnet production.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has been selected for significant government funding to accelerate rare earth refining and magnet recycling, marking a major step in Brazil’s strategic push for a secure, sustainable supply chain.

Vulcan Energy has received building permits for its 30MW geothermal renewable energy plant in Germany, advancing its goal of carbon-neutral lithium production for Europe’s battery industry.

Minbos Resources reports strong 2024-25 field trial results for its phosphate fertilizer PRIMEIRO™ in Angola, while expanding its product range with PRIMEIRO PLUS+, a blended NPKS solution tailored to local soils and crops.

Empire Energy Group has successfully closed and upsized its Share Purchase Plan to $7 million, raising crucial funds to advance its Beetaloo Basin projects. The capital raise strengthens the company’s cash position ahead of key operational milestones.

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

Hazel Group Limited has temporarily paused trading of its securities on the ASX, signaling an impending announcement that investors will want to watch closely.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.